{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:45:38Z","timestamp":1786981538562,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11060-024-04733-z","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T12:19:44Z","timestamp":1719490784000},"page":"391-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location"],"prefix":"10.1007","volume":"169","author":[{"given":"Souhir","family":"Guidara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Seyve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Poncet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Leonce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Paul","family":"Bringuier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"McLeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Cartalat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiebaud","family":"Picart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Hench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Meyronet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Ducray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Barritault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"4733_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro-Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro-Oncol"},{"key":"4733_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR et al (2016) HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat 37:564\u2013569. https:\/\/doi.org\/10.1002\/humu.22981","journal-title":"Hum Mutat"},{"key":"4733_CR3","doi-asserted-by":"publisher","unstructured":"Tauzi\u00e8de-Espariat A, Debily M, Castel D et al (2022) Deciphering the genetic and epigenetic landscape of pediatric bithalamic tumors. Brain Pathol 32. https:\/\/doi.org\/10.1111\/bpa.13039","DOI":"10.1111\/bpa.13039"},{"key":"4733_CR4","doi-asserted-by":"publisher","unstructured":"L\u00f3pez G, Oberheim Bush NA, Berger MS et al (2017) Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma. Acta Neuropathol Commun 5. https:\/\/doi.org\/10.1186\/s40478-017-0440-x","DOI":"10.1186\/s40478-017-0440-x"},{"key":"4733_CR5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01134","author":"I Arrillaga-Romany","year":"2024","unstructured":"Arrillaga-Romany I, Gardner SL, Odia Y et al (2024) ONC201 (Dordaviprone) in recurrent H3 K27M\u2013Mutant diffuse midline glioma. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.23.01134","journal-title":"J Clin Oncol"},{"key":"4733_CR6","doi-asserted-by":"publisher","unstructured":"Odia Y, Hall MD, Cloughesy TF et al (2024) Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort. https:\/\/doi.org\/10.1093\/neuonc\/noae021. Neuro-Oncol","DOI":"10.1093\/neuonc\/noae021"},{"key":"4733_CR7","doi-asserted-by":"publisher","first-page":"D747","DOI":"10.1093\/nar\/gkl995","volume":"35","author":"H Parkinson","year":"2007","unstructured":"Parkinson H, Kapushesky M, Shojatalab M et al (2007) ArrayExpress\u2013a public database of microarray experiments and gene expression profiles. Nucleic Acids Res 35:D747\u2013D750. https:\/\/doi.org\/10.1093\/nar\/gkl995","journal-title":"Nucleic Acids Res"},{"key":"4733_CR8","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkab1059","volume":"50","author":"MA Freeberg","year":"2022","unstructured":"Freeberg MA, Fromont LA, D\u2019Altri T et al (2022) The European Genome-Phenome Archive in 2021. Nucleic Acids Res 50:D980\u2013D987. https:\/\/doi.org\/10.1093\/nar\/gkab1059","journal-title":"Nucleic Acids Res"},{"key":"4733_CR9","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2012","unstructured":"Barrett T, Wilhite SE, Ledoux P et al (2012) NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res 41:D991\u2013D995. https:\/\/doi.org\/10.1093\/nar\/gks1193","journal-title":"Nucleic Acids Res"},{"key":"4733_CR10","unstructured":"Plan France (2025) M\u00e9decine G\u00e9nomique 2025. In: PFMG https:\/\/pfmg2025.aviesan.fr\/. Accessed 29 Mar 2024"},{"key":"4733_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40478-024-01759-2","volume":"12","author":"J Hench","year":"2024","unstructured":"Hench J, Hultschig C, Brugger J et al (2024) EpiDiP\/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnostics. Acta Neuropathol Commun 12:51. https:\/\/doi.org\/10.1186\/s40478-024-01759-2","journal-title":"Acta Neuropathol Commun"},{"key":"4733_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474. https:\/\/doi.org\/10.1038\/nature26000","journal-title":"Nature"},{"key":"4733_CR13","doi-asserted-by":"publisher","unstructured":"Val\u00e9rio E, Alves de Castro JV, Carraro DM et al (2022) Beyond midline: diffuse Hemispheric Glioma, H3 K27M-Mutant with aggressive behavior. https:\/\/doi.org\/10.1093\/jnen\/nlac016. J Neuropathol Exp Neurol nlac016","DOI":"10.1093\/jnen\/nlac016"},{"key":"4733_CR14","doi-asserted-by":"publisher","unstructured":"Donev K, Sundararajan V, Johnson D et al (2024) Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered? J. https:\/\/doi.org\/10.1093\/jnen\/nlae018. Neuropathol Exp Neurol","DOI":"10.1093\/jnen\/nlae018"},{"key":"4733_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of Glioblastoma. Cancer Cell 22:425\u2013437. https:\/\/doi.org\/10.1016\/j.ccr.2012.08.024","journal-title":"Cancer Cell"},{"key":"4733_CR16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/neuonc\/now274","volume":"19","author":"D Meyronet","year":"2017","unstructured":"Meyronet D, Esteban-Mader M, Bonnet C et al (2017) Characteristics of H3 K27M-mutant gliomas in adults. Neuro-Oncol 19:1127\u20131134. https:\/\/doi.org\/10.1093\/neuonc\/now274","journal-title":"Neuro-Oncol"},{"key":"4733_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdaa142","author":"JD Schulte","year":"2020","unstructured":"Schulte JD, Buerki RA, Lapointe S et al (2020) Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Neuro-Oncol Adv. https:\/\/doi.org\/10.1093\/noajnl\/vdaa142. 2:","journal-title":"Neuro-Oncol Adv"},{"key":"4733_CR18","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41588-022-01236-3","volume":"54","author":"I Liu","year":"2022","unstructured":"Liu I, Jiang L, Samuelsson ER et al (2022) The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location. Nat Genet 54:1881\u20131894. https:\/\/doi.org\/10.1038\/s41588-022-01236-3","journal-title":"Nat Genet"},{"key":"4733_CR19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00401-020-02142-w","volume":"139","author":"D Castel","year":"2020","unstructured":"Castel D, Kergrohen T, Tauzi\u00e8de-Espariat A et al (2020) Histone H3 wild-type DIPG\/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation. Acta Neuropathol (Berl) 139:1109\u20131113. https:\/\/doi.org\/10.1007\/s00401-020-02142-w","journal-title":"Acta Neuropathol (Berl)"},{"key":"4733_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/neuonc\/noaa251","volume":"23","author":"P Sievers","year":"2021","unstructured":"Sievers P, Sill M, Schrimpf D et al (2021) A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR. Neuro-Oncol 23:34\u201343. https:\/\/doi.org\/10.1093\/neuonc\/noaa251","journal-title":"Neuro-Oncol"},{"key":"4733_CR21","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D et al (2017) Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and diffuse intrinsic pontine glioma. Cancer Cell 32:520\u2013537e5. https:\/\/doi.org\/10.1016\/j.ccell.2017.08.017","journal-title":"Cancer Cell"},{"key":"4733_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00401-023-02609-6","volume":"146","author":"EA Williams","year":"2023","unstructured":"Williams EA, Brastianos PK, Wakimoto H et al (2023) A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4. Acta Neuropathol (Berl) 146:515\u2013525. https:\/\/doi.org\/10.1007\/s00401-023-02609-6","journal-title":"Acta Neuropathol (Berl)"},{"key":"4733_CR23","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","volume":"36","author":"LM Hoffman","year":"2018","unstructured":"Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N et al (2018) Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG Registries. J Clin Oncol 36:1963\u20131972. https:\/\/doi.org\/10.1200\/JCO.2017.75.9308","journal-title":"J Clin Oncol"},{"key":"4733_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00401-020-02259-y","volume":"141","author":"U Sch\u00fcller","year":"2021","unstructured":"Sch\u00fcller U, Iglauer P, Dorostkar MM et al (2021) Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations. Acta Neuropathol (Berl) 141:323\u2013325. https:\/\/doi.org\/10.1007\/s00401-020-02259-y","journal-title":"Acta Neuropathol (Berl)"},{"key":"4733_CR25","doi-asserted-by":"publisher","unstructured":"Auffret L, Ajlil Y, Tauzi\u00e8de-Espariat A et al (2024) A new subtype of diffuse midline glioma, H3 K27 and BRAF\/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation. Acta Neuropathol (Berl) 147. https:\/\/doi.org\/10.1007\/s00401-023-02651-4","DOI":"10.1007\/s00401-023-02651-4"},{"key":"4733_CR26","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3171\/2019.9.JNS191920","volume":"133","author":"T Qiu","year":"2020","unstructured":"Qiu T, Chanchotisatien A, Qin Z et al (2020) Imaging characteristics of adult H3 K27M-mutant gliomas. J Neurosurg 133:1662\u20131670. https:\/\/doi.org\/10.3171\/2019.9.JNS191920","journal-title":"J Neurosurg"},{"key":"4733_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.wneu.2019.08.024","volume":"131","author":"G La Rocca","year":"2019","unstructured":"La Rocca G, Sabatino G, Altieri R et al (2019) Significance of H3K27M mutation in Nonmidline High-Grade gliomas of cerebral hemispheres. World Neurosurg 131:174\u2013176. https:\/\/doi.org\/10.1016\/j.wneu.2019.08.024","journal-title":"World Neurosurg"},{"key":"4733_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.humpath.2018.04.015","volume":"78","author":"L Wang","year":"2018","unstructured":"Wang L, Li Z, Zhang M et al (2018) H3 K27M\u2013mutant diffuse midline gliomas in different anatomical locations. Hum Pathol 78:89\u201396. https:\/\/doi.org\/10.1016\/j.humpath.2018.04.015","journal-title":"Hum Pathol"},{"key":"4733_CR29","doi-asserted-by":"publisher","unstructured":"Wang Y, Feng L, Ji P et al (2021) Clinical features and molecular markers on diffuse midline gliomas with H3K27M mutations: a 43 cases retrospective cohort study. https:\/\/doi.org\/10.3389\/fonc.2020.602553. Front Oncol 10:","DOI":"10.3389\/fonc.2020.602553"},{"key":"4733_CR30","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","volume":"603","author":"RG Majzner","year":"2022","unstructured":"Majzner RG, Ramakrishna S, Yeom KW et al (2022) GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature 603:934\u2013941. https:\/\/doi.org\/10.1038\/s41586-022-04489-4","journal-title":"Nature"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04733-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04733-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04733-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:32:21Z","timestamp":1724412741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04733-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4733"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04733-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This observational retrospective study is in accordance with local and European legislation regarding consents of patients to participate in a research study and consents to publish. It was approved by our institutional research ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards and consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}